Farnesoid x receptor (FXR), deficiency of which mediates diabetes acceleration of nephropathy in T1DM, inhibits SREBP-2 and elevates miR-29a, thus relieving renal fibrosis. This evidence concerns the gene NR1H4 and type 1 diabetes mellitus.